In our study, we established and validated the ‘false positive’ cutoff for ALK FISH in CTCs using 12 blood samples from NSCLC ALK-negative patients and five blood samples from healthy donors (Supplementary Data). The gene discussed is ALK; the disease is non-small cell lung carcinoma.